This work is licensed under the Creative Commons Attribution 4.0 International License.
Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13(6):368–78.ZiaeianBFonarowGCEpidemiology and aetiology of heart failure20161363687810.1038/nrcardio.2016.25486877926935038Search in Google Scholar
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200.PonikowskiPVoorsAAAnkerSD2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC20163727212920010.1002/ejhf.59227207191Search in Google Scholar
Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the Heart. Methodist Debakey Cardiovasc J. 2017;13(2):60–3.OsunaPMUdovcicMSharmaMDHyperthyroidism and the Heart201713260310.14797/mdcj-13-2-60551268028740583Search in Google Scholar
Danzi S, Klein I. Thyroid disease and the cardiovascular system. Endocrinol Metab Clin North Am. 2014;43(2):517–28.DanziSKleinIThyroid disease and the cardiovascular system20144325172810.1016/j.ecl.2014.02.00524891175Search in Google Scholar
Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin e Investig en Arterioscler. 2014;26(6):296–309.Vargas-UricoecheaHBonelo-PerdomoASierra-TorresCHEffects of thyroid hormones on the heart201426629630910.1016/j.arteri.2014.07.00325438971Search in Google Scholar
Ellis ER, Josephson ME. What About Tachycardia-induced Cardiomyopathy? Arrhythmia Electrophysiol Rev. 2013;2(2):82–90.EllisERJosephsonMEWhat About Tachycardia-induced Cardiomyopathy?201322829010.15420/aer.2013.2.2.82471157326835045Search in Google Scholar
Collet J-P, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020:ehaa575.ColletJ-PThieleHBarbatoE2020ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation2020ehaa57510.1093/eurheartj/ehaa90933186459Search in Google Scholar
Her K, Choi CW, Park YW, Shin HK, Won YS. Concomitant Peripheral Artery Disease and Asymptomatic Coronary Artery Disease: A Management Strategy. Ann Vasc Surg. 2008;22(5):649–56.HerKChoiCWParkYWShinHKWonYSConcomitant Peripheral Artery Disease and Asymptomatic Coronary Artery Disease: A Management Strategy20082256495610.1016/j.avsg.2008.01.01018504099Search in Google Scholar
Adán V, Crown LA. Diagnosis and treatment of sick sinus syndrome. Am Fam Physician. 2003;67(8):1725–32.AdánVCrownLADiagnosis and treatment of sick sinus syndrome2003678172532Search in Google Scholar
Klaeboe LG, Edvardsen T. Echocardiographic assessment of left ventricular systolic function. J Echocardiogr. 2019;17(1):10–6.KlaeboeLGEdvardsenTEchocardiographic assessment of left ventricular systolic function201917110610.1007/s12574-018-0405-530390189Search in Google Scholar
Kusunose K, Torii Y, Yamada H, et al. Clinical Utility of Longitudinal Strain to Predict Functional Recovery in Patients With Tachyarrhythmia and Reduced LVEF. JACC Cardiovasc Imaging. 2017;10(2):118–26.KusunoseKToriiYYamadaHClinical Utility of Longitudinal Strain to Predict Functional Recovery in Patients With Tachyarrhythmia and Reduced LVEF20171021182610.1016/j.jcmg.2016.03.01927665160Search in Google Scholar
Han FT, Kiser R, Nixon J V., Wood MA, Ellenbogen KA. What is the time course of reversal of tachycardia-induced cardiomyopathy? Europace. 2011;13(1):139–41.HanFTKiserRNixonJ V.WoodMAEllenbogenKAWhat is the time course of reversal of tachycardia-induced cardiomyopathy?20111311394110.1093/europace/euq29820682551Search in Google Scholar
Mueller KAL, Heinzmann D, Klingel K, et al. Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy. J Am Coll Cardiol. 2017;69(17):2160–72.MuellerKALHeinzmannDKlingelKHistopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy2017691721607210.1016/j.jacc.2017.02.04928449778Search in Google Scholar
Addison D, Farhad H, Shah R V., et al. Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation. J Am Heart Assoc. 2016;5(9):e003570.AddisonDFarhadHShahR V.Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation201659e00357010.1161/JAHA.116.003570507902227671316Search in Google Scholar
Neilan TG, Shah R V., Abbasi SA, et al. The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation. J Am Coll Cardiol. 2013;62(23):2205–14.NeilanTGShahR V.AbbasiSAThe incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation2013622322051410.1016/j.jacc.2013.07.067390887223994399Search in Google Scholar
Curtis AB, Worley SJ, Adamson PB, et al. Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction. N Engl J Med. 2013;368(17):1585–93.CurtisABWorleySJAdamsonPBBiventricular Pacing for Atrioventricular Block and Systolic Dysfunction20133681715859310.1056/NEJMoa121035623614585Search in Google Scholar
Gasparini M, Leclercq C, Lunati M, et al. Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation. The CERTIFY Study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). JACC Hear Fail. 2013;1(6):500–7.GaspariniMLeclercqCLunatiMCardiac Resynchronization Therapy in Patients With Atrial Fibrillation. The CERTIFY Study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry)201316500710.1016/j.jchf.2013.06.00324622002Search in Google Scholar
Watanabe H, Okamura K, Chinushi M, et al. Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy. Int Heart J. 2008;49(1):39–47.WatanabeHOkamuraKChinushiMClinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy2008491394710.1536/ihj.49.3918360063Search in Google Scholar